Article

American Oncology Network Remains Committed to Closing the Gap in Cancer Care

The American Oncology Network is committed to reducing health inequities and close the gap in cancer care.

Cancer remains the leading cause of death in the United States, with more than 1.8 million Americans receiving a cancer diagnosis every year and 600,000 dying. While there have been advances in prevention, diagnosis, and treatment, barriers to care continue to negatively impact cancer care.

Most Americans receiving cancer treatment do so in community oncology practices, which are able to cloes the gap in cancer care becaues they provide easy and convenient access to care and a cmoprehensive range of treatments close to the patient's home. With 70 clinics in 16 states, the American Oncology Network (AON), continues to strive to close the cancer care gap by providing affordable care that is close to home.

“We have made great strides in just three years,” AON CEO Todd Schonherz said in a statement. “Close to 160,000 patients have received treatment at AON clinics across the country and we’ve welcomed over 70,000 new patients. Our in-house laboratory has processed over 7.7 million clinical lab tests and almost 6100 pathology specimens. And our specialty pharmacy has delivered over 63,540 scripts.”


Read more.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
H. John Beardsley, MBA, and Fauzea Hussain, MPH, sitting for a video interview
Dr Margrit Wiesendanger
Ibrahim Aldoss, MD, associate professor, City of Hope
Manmeet Ahluwalia, MD, MBA, FASCO, chief of medical oncology, chief scientific officer, and deputy director of the Miami Cancer Institute of Baptist Health South Florida
Cathy Eng, MD, FACP, FASCO
Dr Margrit Wiesendanger
Nini Wu, MD, Navista
Fred Locke, MD, Moffitt Cancer Center and Research Institute
Dr Margrit Wiesendanger
Tom Belmon, CAP, GPBCH
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo